**Author details**

Linda Baumgartner1 , Michael Seidman2 , Deborah Lamontagne3 , Ernest Moore4 , David Shook<sup>5</sup> , Steven Messina6 and James Baumgartner7 \*

1 Clarke School for Hearing and Speech, and Little HEARoes, Orlando, Florida, USA

2 Department of Otorhinolaryngology, College of Medicine, Advent Health Celebration and University of Central Florida, Orlando, Florida, USA

3 University of Tennessee, Memphis Tennessee, USA

4 University of North Texas, Denton, Texas, USA

5 Advent Health Orlando, Orlando, Florida, USA

6 Department of Radiology (Neuroradiology), Mayo Clinic College of Medicine, Rochester, MN, USA

7 Department of Neurological Surgery, College of Medicine, Advent Health Orlando and University of Central Florida, Orlando, Florida, USA

\*Address all correspondence to: lbaumgartenr@clarkeschools.org

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**67**

*Progenitor Cell Therapy for Sensorineural Hearing Loss in Infants*

[9] Seidman MD, Khan MJ, Tang WX, Quirk WS. Influence of lecithin on mitochondrial DNA and age-related hearing loss. Otolaryngology – Head and Neck Surgery Journal.

[10] Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues.

[11] Cox CS Jr, Baumgartner JE, Harting MT, Worth LL, Walker PA, Shah SK, et al. Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children. Neurosurgery. 2011;**65**:588-600

[12] Vahidy FS, Rahbar MH, Shu H, Rowan PJ, Bambhroliya AB, Savitz SI. Systematic review and metanalysis of bone marrow-derived mononuclear cells in animal models of ischemic stroke.

[13] Savitz SI, Mistra V, Kasam M, Junija H, Cox CS Jr, Alderman S. Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Annals of

outcomes in cervical spinal cord injury.

Stroke. 2016;**47**:1632-1639

Neurology. 2011;**70**:59-69

[14] White SV, Czisch CE, Han MH, Plant CE, Harvey AT, Plant GW. Intravenous transplantation of mesenchymal progenitors distributes solely to the lungs and improve

Stem Cells. 2016;**34**:1812-1825

Research. 2017;**95**:1225-1236

[16] van Velthoven CT, Sheldon RA, Kavelaars A, Derugin N, Vexler ZS, Willement HO, et al. Mesenchymal stem

[15] van Velthoven CT, Dzietko M, Wenddland MR, Derugin N, Faustino J, Heijnen CG, et al. Mesenchymal stem cells attenuate MRI-identified injury, protect white matter and long-term functional outcome after neonatal focal stroke in rats. Journal of Neuroscience

2002;**127**(3):138-144

Science. 1997;**276**:7-14

*DOI: http://dx.doi.org/10.5772/intechopen.87147*

[1] Lin FR, Niparko JK, Ferrucci L. Hearing loss prevalence in the United States. Archives of Internal Medicine.

[2] Mehra S, Eavey RD, Keamy DG Jr. The epidemiology of hearing impairment in the United States: Newborns, infants and adolescents. Otolaryngology and Head and Neck

[3] Baumgartner LS, Moore E, Shook D, Messina S, Day MD, Green J, et al. Safety of autologous umbilical cord blood therapy for acquired sensorineural hearing loss in children. Journal of Audiology and Otology.

[4] Shibata SB, Shearer AE, Smith RJH. Genetic sensorineural hearing loss. In: Flint PW, Haughey BH, Lund VJ, Niparko JK, Robbins DT, Thomas JR, editors. Cummings Otolaryngology-

Head and Neck Surgery. 6th ed. Philadelphia, PA: An Imprint of Elsevier; 2014. pp. 2285-2300

[5] Canalis RF, Lambert PR. The Ear: Comprehensive Otology. 1st ed. Philadelphia, PA: Lippincott, Williams

[6] Smith RJ, Bale FJ Jr, White KR. Sensorineural hearing loss in children. Lancet. 2005;**365**:879-890

[7] Seidman MD, Bai U, Khan MJ, Murphy MP, Quirk WS, Castora FJ, et al. Association of mitochondrial DNA deletions and cochlear pathology: A molecular biologic tool. The Laryngoscope.

[8] Bai U, Seidman MD. A specific mitochondrial DNA deletion

(mtDNA4977) is identified in a pedigree of a family with hearing loss. Hearing

1996;**106**(6):777-783

Research. 2001;**154**:73-80

Surgery. 2009;**140**:461-472

2018;**22**(4):209-222

and Wilkins; 2000

**References**

2011;**171**:1851-1852

*Progenitor Cell Therapy for Sensorineural Hearing Loss in Infants DOI: http://dx.doi.org/10.5772/intechopen.87147*
